Skip to content

Caribbean Region

Partners and related Agencies / Organizations

Last Updated on Friday, 25 July 2014 13:41

Rational use of medicines

Improve rational use of medicines by health professionals and consumers
Last Updated on Friday, 25 July 2014 13:38

NRAs Quality and Regulation

Quality and Regulation: To support the strengthening of core functions of NRAs and the development of a sub-regional regulatory framework

Last Updated on Friday, 25 July 2014 13:38

Equitable Access and Innovation

Equitable Access and Innovation: support the strengthening of integrated supply systems and using of intellectual property flexibilities

Last Updated on Friday, 25 July 2014 13:01

Pharmaceutical Policy in the Caribbean



  • To support the development of a Caribbean Pharmaceutical Policy within the CCH III framework and to support development/updating and implementation of National Pharmaceutical Policies in selected countries as part of the steering role of the State and essential public health functions;
Last Updated on Friday, 25 July 2014 13:38

Technical Cooperation

The technical cooperation in the area of medicines and health technologies is framed by the Sub-regional Cooperation Strategy (SCS) for the Caribbean: 2010-2015 and the WHO Medicines Strategy: 2008-2013, in line with the Caribbean mandates, such as the Caribbean Cooperation in Health, phase 3 (CCH III)  and its goal related to health systems responding effectively to the needs of the Caribbean people and thePort of Spain Declaration , that states that by 2012, 80% of people with non communicable diseases (NCDs) would receive quality care and have access to preventative education, based on regional guidelines; taking into account the implementation of the Caribbean Regional Public Health Agency (CARPHA) and the CARICOM Single Market and Economy (CSME).

Last Updated on Friday, 25 July 2014 13:38

Medicines and Biologicals in the Caribbean

PAHO/WHO’s strategic goal of technical cooperation in this area is to support countries in attaining “Equitable Access to essential medical products and technologies to assured quality, safety and efficacy, cost effectiveness, and cost-effective use”.

Caribbean countries known as Small Islands Development States (SIDS) have several commonalities, including high public and private expenditure on medicines and challenges for regulation and enforcement and guaranteeing quality and safety of medicines.  This expose the population to treats like counterfeit or falsified and/or sub-standard medicines among other problems.

In the Caribbean, the overall objective of the technical cooperation is improving availability, affordability and rational use of quality and safe medicines in the Caribbean, in order to contribute for the achievement of the Millennium Development Goals (MDG)  related to health in the Caribbean countries, namely, acute and non-communicable diseases (MDG 8); reduce child mortality (MDG 4), improve women's health (MDG 5) and lower the burden of HIV/AIDS, malaria, tuberculosis and other diseases (MDG 6).


  Medicines and Biological in the Caribbean - Areas of Work 


Last Updated on Friday, 25 July 2014 15:04

Regional Office for the Americas of the World Health Organization
525 Twenty-third Street, N.W., Washington, D.C. 20037, United States of America
Tel.: +1 (202) 974-3000 Fax: +1 (202) 974-3663

© Pan American Health Organization. All rights reserved.